Actively Recruiting
Generating Advancements Through Longitudinal Analysis in X and Y Variations
Led by University of Colorado, Denver · Updated on 2024-04-18
5000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Colorado, Denver
Lead Sponsor
C
Children's Hospital Colorado
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are conducting the GALAXY Registry study to learn more about individuals with X and Y chromosome variations, also known as sex chromosome aneuploidies. This observational study aims to collect detailed information from medical records of hundreds of patients seen at various clinics across the United States. The goal is to improve health outcomes and the care provided to people with these genetic variations. The study does not involve any treatment or intervention. Instead, it gathers data such as genetic test results, imaging, medications, and other health information over time. The registry collects this data longitudinally, following participants for up to 15 years to observe the development of various health conditions. Participants provide access to their medical records, and researchers track the occurrence of health conditions, including mental health diagnoses, obesity, dyslipidemia, hypertension, hypothyroidism, hyperthyroidism, and diabetes. The study monitors these outcomes from the start and continues for up to 15 years. Participants of all ages and genders can join, and the study includes regular data collection without requiring additional treatments or procedures.
CONDITIONS
Brief Title
Generating Advancements Through Longitudinal Analysis in X and Y Variations (GALAXY)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Genetically-confirmed diagnosis of a sex chromosome aneuploidy condition
- Any age
- Any gender
- Informed consent for individuals over 18 years of age, parent or guardian permission for individuals under 18, or proxy consent from legally authorized representative if decision making is impaired
You will not qualify if you...
- Lack of documentation of genetic testing confirming sex chromosome aneuploidy diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 15 years
Participants are observed over time to collect health data related to various conditions without receiving any treatment intervention.
Periodic visits as scheduled during the study
Trial Site Locations
Total: 1 location
1
Children's Hospital Colorado
Aurora, Colorado, United States, 80045
Actively Recruiting
Research Team
S
Shanlee M Davis, MD, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here